YOLFTbeta
67

Taiwan Advanced Nanotech Inc.

6797 · TWO · Healthcare / Medical Devices

10.40TWD+0.46 (+4.63%)

Price History

Full chart

Market Stats

Previous Close9.94
Open9.99
Day Range9.70 – 10.40
52-Week Range10.40 – 19.75
Volume10.88K
Market Cap345.74M
P/E (TTM)0.00
Forward P/E0.00
EPS-7.14
Dividend Yield0.00%
Beta0.36
50-Day Avg11.96
200-Day Avg13.98

About

Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Chien Hsing Chien
  • HeadquartersNo.188, Wenhe Road, Taoyuan City, Taiwan, Taiwan
  • Websitehttps://www.tanbead.com

Leadership

  • Mr. Chien Hsing ChienFounder, CEO, GM & Director
  • Zhibao ZhangAccounting Supervisor

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue113.96M1.72B1.93B1.33B245.61M197.59M154.37M
Growth (%)-+1408.49%+12.18%-31.21%-81.48%-19.55%-21.87%
Cost of Revenue89.30M761.02M861.06M676.86M276.72M227.65M230.17M
Gross Profit24.66M958.06M1.07B649.67M-31.11M-30.06M-75.80M
Gross Margin21.64%55.73%55.35%48.98%-12.67%-15.21%-49.10%
Operating Expense70.22M161.21M266.50M305.61M230.28M177.21M156.55M
Operating Income-45.56M796.85M800.84M344.06M-261.39M-207.27M-232.35M
Operating Margin-39.98%46.35%41.53%25.94%-106.42%-104.90%-150.51%
EBITDA-30.30M806.14M879.49M577.45M-114.06M-73.64M-117.15M
EBITDA Margin-26.59%46.89%45.61%43.53%-46.44%-37.27%-75.89%
Net Income-36.60M618.19M626.04M326.00M-208.19M-190.57M-226.61M
Net Income Margin-32.12%35.96%32.46%24.58%-84.76%-96.45%-146.79%
R&D23.96M42.58M82.21M108.56M82.99M56.22M53.65M
R&D as % of Total Revenue21.03%2.48%4.26%8.18%33.79%28.45%34.75%
Interest Expense295.00K1.03M5.66M5.55M8.75M5.40M6.00M
Interest Expense % of Total Revenue0.26%0.06%0.29%0.42%3.56%2.73%3.89%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets234.86M1.88B2.20B2.33B1.79B1.38B1.25B
Total Liabilities87.45M935.03M923.67M818.64M597.53M368.69M476.51M
Total Equity147.42M948.11M1.27B1.48B1.19B1.01B772.40M
Cash98.33M665.23M369.45M710.93M432.59M298.79M193.25M
Total Debt67.44M356.35M508.44M433.78M490.68M293.04M-
Net Debt-30.89M-308.88M138.99M-277.15M58.09M-5.76M36.75M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-24.83M703.35M703.42M406.64M-317.24M-18.80M-20.96M
Investing Cash Flow-10.91M-263.27M-744.08M136.63M10.26M104.77M-
Financing Cash Flow22.69M152.46M-255.12M-201.79M28.64M-219.76M-
Capital Expenditure12.63M127.83M180.29M47.17M52.65M1.51M2.45M
Free Cash Flow-37.46M575.53M523.13M359.48M-369.89M-20.31M-23.41M
Dividends Paid--294.88M139.01M91.44M--
FCF to OCF150.89%81.83%74.37%88.40%116.60%108.04%111.68%
Dividend Paid to FCF--56.37%38.67%-24.72%--

Key Statistics & Ratios

Market Cap345.74M
Enterprise Value-19.18M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.03
Price / Book0.50
EPS-7.14
Book Value22.04
Revenue (TTM)170.57M
Gross Profit (TTM)-99.05M
EBITDA-189.92M
Profit Margin-126.55%
Operating Margin-143.37%
Return on Equity-27.83%
Return on Assets-13.07%
Shares Outstanding30.06M
Shares Float18.44M
Beta0.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
3.00Jun 19, 2023
20221×
6.00Jun 24, 2022
20211×
10.77Jun 2, 2021

Stock Splits

  • Jun 24, 20221300:1000
  • Jun 2, 20211100:1000